Tokuda Hospital

Sofia 1407

1 studies enrolling now · 4 studies all time

What they study most

Hepatitis C, Chronic, Moderate to Extensive Hepatic Fibrosis (METAVIR F3-4), Moderately to Severely Active Crohns Disease, Multiple Sclerosis

Studies at this site

• A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• Oral Cladribine in Early Multiple Sclerosis (MS) — Completed
• Phase 1b/2, Open Label, Repeat Dose, Dose Escalation Study of ND-L02-s0201 Injection in Subjects With Moderate to Extensive Fibrosis (METAVIR F3-4) — Completed
• Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV — Completed